![Mary Joan Hampson-Carlin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mary Joan Hampson-Carlin
Corporate Officer/Principal at Laureate Biopharmaceutical Services, Inc.
Profile
Mary Joan Hampson-Carlin is currently the Vice President-Quality Systems at Laureate Biopharmaceutical Services, Inc. She completed her undergraduate degree at Quinnipiac University and her MBA at the University of New Haven.
Mary Joan Hampson-Carlin active positions
Companies | Position | Start |
---|---|---|
Laureate Biopharmaceutical Services, Inc.
![]() Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 30/07/2009 |
Training of Mary Joan Hampson-Carlin
Quinnipiac University | Undergraduate Degree |
University of New Haven | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Laureate Biopharmaceutical Services, Inc.
![]() Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Mary Joan Hampson-Carlin